Stockreport

SciSparc-Clearmind Medicine Collaboration Leads to Publication of Application for Innovative Ketamine-Based Combination [Yahoo! Finance]

Clearmind Medicine Inc.  (CMND) 
PDF company focusing on the development of therapies to treat disorders and rare diseases of the central nervous system, announced today that as part of its ongoing collabor [Read more]